Initiator Pharma: Recruitment completed in phase IIb trial - Redeye

Redeye leaves a short comment following the announcement of completed patient recruitment in Initiator Pharma’s ongoing phase IIb study with pudafensine. We are encouraged by the news and look forward to the data readout in Q4 2023.

Länk till analysen i sin helhet: https://www.redeye.se/research/918985/initiator-pharma-recruitment-completed-in-phase-iib-trial?utm_source=finwire&utm_medium=RSS